Political origins of antitrust. The Sherman Antitrust Act of 1890 was the political manifestation of strong currents of discontentment among farmers and small business during the Reconstruction era.
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
Political origins of antitrust
The Sherman Antitrust Act of 1890 was the political manifestation of strong currents of discontentment among farmers and small business during the Reconstruction era.
Read Columbia Univ. Law Professor Eblen Moglen’s views on the origins of antitrust(pdf format)
Why were farmers angry?
Antitrust enforcement: Who is responsible?
Arkansas Attorney General Mark Pryor sued Mylon for price-fixing, a section 1 violation.
FOR IMMEDIATE RELEASE Contact: Michael Teague July 13, 2000 (501) 682-0517 LITTLE ROCK - A lawsuit filed in 1999 by Attorney General Mark Pryor, 32 other state attorneys general, and the Federal Trade Commission (FTC), alleging an illegal astronomical price increase for two drugs used to treat Alzheimer's disease and other disorders, has been settled in principle for $100 million by pharmaceutical giant Mylan Laboratories and three other defendants.
The states and the FTC filed parallel lawsuits to protect consumers from a price-fixing and monopolization scheme led by Mylan. In addition to the amount of restitution and damages of the settlement, Mylan has agreed to restore competitive balance to the pharmaceutical market.
Under terms of the agreement, Arkansas is expected to receive between $1.5 and $2 million to benefit state agencies and consumers who have paid inflated prices for the Mylan products in question. The amount of money Arkansas will receive will be determined in large part by the amount of money Arkansas consumers and state agencies have spent on clorazepate and lorazepam in 1998 and 1999
Congress create a strong incentive for private antitrust litigation
Private antitrust enforcement